Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Dec 23, 2020
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- AHRQ Notice of Extension of PA-18-793
Agency for Healthcare Research and Quality
Notice of Changes to Funding Opportunities
- Notice of Changed Application Forms for RFA-CA-20-049 "New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)"
National Cancer Institute
- Notice of Change of Key Dates for RFA-HD-22-003 "Contraception Development Research Center Program (P50 Clinical Trial Optional)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Clarification to Career Stages Supported for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke
National Institute of Mental Health
- Notice of Change to Award Budget for PHS 2020-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
National Institutes of Health
- Notice of NCATS Withdrawal from Participation in PAR-20-243, "Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)"
National Center for Advancing Translational Sciences
- Notice of NCATS Withdrawal from Participation in PAR-20-165, "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)"
National Center for Advancing Translational Sciences
- Notice of NCATS Withdrawal from Participation in PAR-20-168, "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)"
National Center for Advancing Translational Sciences
Requests for Proposal
- Pre Solicitation Notice: Clinical Pharmacology Quality Assurance (CPQA) Program, RFP: 75N93021R00003
National Institute of Allergy and Infectious Diseases
Notices of Special Interest
- Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease
National Institute on Aging
- Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
- Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
National Institute of Mental Health
National Eye Institute
National Institute on Aging
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
National Center for Advancing Translational Sciences
Funding Opportunities
- NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
National Institute on Deafness and Other Communication Disorders
- NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
National Institute on Deafness and Other Communication Disorders
- Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed)
Only awardees supported under the following FOAs are eligible to apply: PAR-12-183, RFA-AG-16-002, PAR-16-406, PAR-17-214, PAR-18-890, PAR-19-234, PAR-16-205
National Institute on Aging
- Engaging the dental workforce to end the HIV epidemic in the U.S. (UG3/UH3 Clinical Trial Required)
National Institute of Dental and Craniofacial Research
- Renewal - Strengthen and Promote the Role of Local Health Departments in Retail Food Safety Regulation (U50 Clinical Trial Not Allowed
Food and Drug Administration
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu